There has been an increase in medicinal cannabis (MC) prescribing and an expansion of pharmacist’s responsibility to ensure its safe and effective use. Based on incident reports and professional practice enquiries from the past year, PDL has identified several key areas of risk associated with the dispensing and supply of cannabis-based therapies and would like to highlight strategies for mitigation.
Potential risks
Dispensing
Below are examples of MC dispensing incidents that PDL are aware of.
Wrong drug or strength: Instances where patients received the incorrect cannabis product o…
